Patricia A. D'amore PhD, MBA

Dr. Patricia A. D’Amore has been at the forefront of angiogenesis research for over three decades. She was a member of the collaborative group from Harvard Medical School that identified vascular endothelial growth factor as the elusive “Factor X” that causes pathological blood vessel growth in blinding neovascular eye diseases. Dr. D’Amore also developed a widely used mouse model of oxygen-induced retinopathy, which has served as the cornerstone of many basic scientific investigations of vascular development and preclinical studies of vascular-targeting agents. Dr. D’Amore’s studies have uncovered important physiological roles of vascular growth factors - yielding crucial insight into the safe use of anti-angiogenic therapies. Her current research focuses on investigating the pathogenesis of dry AMD with a focus on inflammation.

Dr. D’Amore received a Ph.D. in biology from Boston University in 1977 followed by a postdoctoral fellowship in the Department of Ophthalmology and the Department of Physiological Chemistry at Johns Hopkins University School of Medicine. She obtained an MBA from Northeastern University. At Harvard Medical School, Dr. D’Amore is currently the Charles L. Schepens Professor of Ophthalmology, Professor of Pathology, and the Vice-Chair of Basic Research. At Schepens Eye Research Institute, she is the Director of Research, Senior Scientist, and Ankeny Scholar of Retinal Molecular Biology. At Mass. Eye and Ear, is the Director of the Howe Laboratory, Co-Chair of the AMD Center of Excellence, and Associate Chief of Basic and Translational Research. Dr.D’Amore is a Gold Fellow in the Association for Research in Vision and Ophthalmology.